首页 | 本学科首页   官方微博 | 高级检索  
检索        

结节性甲状腺肿术后促甲状腺激素抑制治疗研究进展
引用本文:殷剑光,综述 谈坚,审校.结节性甲状腺肿术后促甲状腺激素抑制治疗研究进展[J].中国普通外科杂志,2017,26(11):1466-1471.
作者姓名:殷剑光  综述 谈坚  审校
作者单位:(上海交通大学医学院附属瑞金医院古北分院/民航上海医院 普通外科|上海 200336)
基金项目:国家自然科学基金资助项目(81172326);上海市慈善癌症研究基金资助项目。
摘    要:结节性甲状腺肿是普通外科领域常见疾病之一,外科手术后有较高的复发率,为后续治疗提出了挑战。而通过术后规范的甲状腺素治疗,可以使患者的术后促甲状腺激素(TSH)抑制,并控制在一个合理的水平,能明显减少结节性甲状腺肿术后的复发。笔者就结节性甲状腺肿术后TSH抑制治疗的进展进行综述。

关 键 词:甲状腺肿,结节性  促甲状腺素  激素替代疗法  综述文献
收稿时间:2017/3/31 0:00:00
修稿时间:2017/10/17 0:00:00

Research progress of thyroid-stimulating hormone suppressive therapy for nodular goiter after surgery
YIN Jianguang,TAN Jian.Research progress of thyroid-stimulating hormone suppressive therapy for nodular goiter after surgery[J].Chinese Journal of General Surgery,2017,26(11):1466-1471.
Authors:YIN Jianguang  TAN Jian
Institution:(Department of General Surgery, Gubei Branch of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine/Civil Aviation Shanghai Hospital, Shanghai 200336, China)
Abstract:Nodular goiter is a common disease in the field of general surgery, and has a high postoperative recurrence rate, which poses a challenge for following treatment. Nevertheless, standardized postoperative thyroxine treatment can effectively reduce postoperative recurrence of the nodular goiter by inhibiting the thyroid-stimulating hormone (TSH) of the patients and controlling it at a proper level after operation. Here, the authors address the progress of postoperative TSH suppressive therapy for nodular goiter patients.
Keywords:Goiter  Nodular  Thyrotropin  Hormone Replacement Therapy  Review
本文献已被 CNKI 等数据库收录!
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号